Methylene Blue, first synthesized by German chemist Heinrich Caro in 1876, is one of the most historically significant compounds in medicine and biology. Originally developed as a synthetic blue dye for the textile industry, it quickly found its place in science. It was identified by Nobel laureate Paul Ehrlich for its selective staining properties of nerve cells and microbes, leading to its distinction as the “first magic bullet” in pharmacology.
Its remarkable history includes being the first fully synthetic drug, the first antiseptic used in clinical practice, and a foundational treatment for malaria for over 60 years. Today, Methylene Blue is the subject of intensive modern research for its unique properties, particularly its role as a redox-cycling agent and its effects on cellular energy metabolism.
Methylene Blue is a heterocyclic aromatic compound belonging to the phenothiazine class. Its distinct deep blue color in its oxidized state is due to its chromophore system. As a salt, it is readily soluble in water.
Methylene Blue’s wide range of biological activities is a subject of ongoing scientific investigation. Its primary mechanism of action is related to its ability to cycle between its oxidized (blue) and reduced (colorless) forms.
At low concentrations, Methylene Blue acts as a unique “electron cycler” within the mitochondria. Research indicates it can accept electrons from NADH and shuttle them directly to Cytochrome C in the electron transport chain (ETC), effectively bypassing Complexes I and II. This process helps maintain mitochondrial membrane potential and supports the continued production of ATP (the primary cellular energy currency), particularly under conditions of metabolic stress or mitochondrial dysfunction. By enhancing the efficiency of the ETC, Methylene Blue may improve cellular respiration and energy output.
Methylene Blue has demonstrated significant neuroprotective potential in various preclinical research models. Its proposed mechanisms include:
Methylene Blue is a potent, reversible inhibitor of Monoamine Oxidase A (MAO-A), an enzyme responsible for breaking down key neurotransmitters like serotonin, melatonin, norepinephrine, and dopamine. Due to this action, Methylene Blue has been studied for its effects on mood and cognition. However, this MAO-A inhibition is also the reason for a critical safety consideration: co-administration with serotonergic agents (such as SSRIs) can lead to a dangerous excess of serotonin, known as serotonin syndrome. This property is a key focus in pharmacological research and safety profiling.
For Research Purposes Only: This product is for laboratory research only by qualified scientists. Not for human use, medical treatment, or veterinary applications. Follow all safety protocols.
Third-party testing is used to confirm the authenticity and quality of our products by ensuring their purity and consistency.
Laboratory-grade vacuum sealed peptides designed for precise, reliable research results.
We’re here to assist with any problems or worries. Hit us up at support@injectify.is or chat with our virtual helper.
Get weekly update about our product on your email, no spam guaranteed we promise ✌️
Featuring Quality Research Compounds like BPC-157, NAD+, 5-Amino-1MQ, and MORE
Explore our Frequently Asked Questions to learn about our website’s regulatory compliance, product usage guidelines, and purchasing terms.
Trusted top producers of Injectable L-Carnitine in North America.
First time visiting our new-look site? Your account has been successfully migrated. Please reset your password here before logging in, by clicking the ‘Forgot Password’ link below: